Newsletter Subject

DOAC Cuts Stroke Risk From Subclinical Afib

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Sun, Nov 12, 2023 11:52 PM

Email Preheader Text

Daily Headlines Sunday, November 12, 2023 Today's Top Stories for {NAME} THE BREAK ROOM CME SPOTLIGH

[MEDPAGE TODAY]( Daily Headlines Sunday, November 12, 2023 Today's Top Stories for {NAME} [MEETING COVERAGE]( [DOAC Cuts Stroke Risk From Subclinical Afib]( [MEETING COVERAGE]( [Health Organizations Making Strides In Health Equity, AMA Leader Says]( [OPINION]( ['Band-Aid on a Gaping Wound': What We Heard This Week]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Evaluating the Cause of Anemia: Diagnosis and Management of Myelodysplastic Syndromes]( [MEETING COVERAGE]( [Promising Debut for CRISPR Gene Editing Therapy for LDL Lowering]( [MEETING COVERAGE]( [MASLD Predicted to Increase by 23% by Middle of the Century]( THE BREAK ROOM [Play Today’s Wordosis]( ADVERTISEMENT [MEETING COVERAGE]( [AMA Declines to Debate Resolution on Israel-Hamas Conflict]( CME SPOTLIGHT [Applying the Latest Clinical Evidence to Treatment Plans for Pediatric Patients With Hodgkin Lymphoma]( [SPECIAL REPORTS]( [U.S. to Cover PrEP for Older Americans to Stem the Spread of HIV]( [MEETING COVERAGE]( [Intensive Blood Pressure Lowering Cuts Dementia Risk]( [MEETING COVERAGE]( [Double Defibrillator More Effective for Obese Afib Patients]( CME SPOTLIGHT [CAR T-Cell Therapy 101]( [OPINION]( [Risk, Value, and 'Doublethink' in Healthcare]( [MEETING COVERAGE]( [Single-Payer Healthcare, Obesity Drug Coverage Discussed at the AMA Interim Meeting]( [MEETING COVERAGE]( [Antihypertensives Do Not Detract From the BP Reduction of a Low-Sodium Diet]( CME SPOTLIGHT [Improving Access to Quality Evidence-Based Care for Acute Myeloid Leukemia]( [MEETING COVERAGE]( [Your Hospital Is Like a Modern Airport. That's Not Good]( [MEETING COVERAGE]( [No Aspirin Needed After LVAD, ARIES-HM3 Trial Says]( [MEETING COVERAGE]( [Tyrosine Kinase Inhibitor Active in Heavily Treated Renal Cell Carcinoma]( CME SPOTLIGHT [Accelerating Adoption of Novel Therapies for Optimal Diffuse Large B-Cell Lymphoma Care]( [MEETING COVERAGE]( [Angioplasty Redeemed for Stable Angina in Sham-Controlled ORBITA-2]( [MEETING COVERAGE]( [Transfusion Thresholds Square Off in Acute Myocardial Infarction]( [PODCASTS]( [Zoonotic Spillovers; DNA and RNA Testing for Cancer Risk]( CME SPOTLIGHT [Advancing cTTP Care Through Integration of the Latest Clinical Evidence]( [OPINION]( [How Will Tomorrow's Medical Students Be Different?]( [OPINION]( [What's the No. 1 Cause of NP Burnout?]( [MEETING COVERAGE]( [Medicine Is Not Just at a Crossroads, It's in a Crisis, AMA President Says]( [MEETING COVERAGE]( [And for Wegovy's Next Trick, Full-Blown Cardiovascular Benefit Outside Diabetes]( # Weekly Survey [Drop Medicare Patients If Pay Cut Goes Through?]( Physicians will face a [3.4% cut in payments]( for their Medicare patients in 2024 unless Congress intervenes[VOTE >]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Daily_DHE?xid=nl_mpt_DHE_2023-11-12&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.